李惠萍 主任医师，教授
硕士招生类型：学术型；专业型
硕士招生专业：内科学（呼吸内科学）
博士招生类型：学术型；专业型
博士招生专业：内科学（呼吸内科学）
所在院系：附属肺科医院
联系方式：liw2013@126.com；**
课题组链接：
研究方向
主要任职
科研业绩

间质性肺疾病、结节病、弥漫性泛细支气管炎
同济大学附属肺科医院呼吸科教授、主任医师（二级）、疑难肺部疾病诊疗中心顾问、卫生部重点专科负责人、呼吸病研究室主任。
中华医学会呼吸病分会委员兼间质病学组副组长（2004-2020）、中国医师协会呼吸医师分会间质病工作委员会副主任委员、华东地区间质病协作组组长、美国 ACCP 资深会员(FCCP)及ATS 会员、上海市医学会呼吸病学分会副主任委员兼间质病学组组长（2003-2020）；
上海市医学会内科专科分会委员、CHEST中文版杂志编委、中华结核和呼吸杂志编委等
Director of Dept. Of Respiratory Medicine in Shanghai Pulmonary Hospital. Initiator of the Clinical Center for Complicated Pulmonary Diseases in Shanghai Pulmonary Hospital, Chief of The Key Department of Chinese National Ministry of Health；
The member of Chinese Society of Respiratory Diseases, Vice Chair of ILD group of Chinese Society of Respiratory Diseases; Vice Chair of Shanghai Academy of Respiratory Diseases; Chairperson of group of ILD of Shanghai Academy of Pulmonary Diseases and the Chairperson of Huadong Cooperation Group of ILD study. the Fellow of ACCP (FCCP) and ATS member. The editor for CHEST（Chinese Version), Chinese Journal of Internal Medicine, International Journal of Respiration, Chinese Journal of Respiratory and Critical Care Medicine. Reviwer for National Natural Science Foundation of China.
首创肺组织靶向糖皮质激素、肺纤维化呼吸操及人工智能肺纤维化分期系统、建立间质性肺疾病鉴别诊断分析系统和临床路径。开发结节病与菌阴结核病鉴别诊断系列新技术，诊断明确率提高74%。创立以阿奇霉素为主的弥漫性泛细支气管炎综合治疗方案，5年生存率超过95%。发明专利授权8项，其中国际专利3项，著作权登记2项。第一作者/通讯作者发表论文180余篇。承担国家自然基金6项（包括重点项目）；主持国家重点专科建设项目，累计科研经费2500余万。主编专著两部。
Original Creation of a novel steroid targeting lung tissue，a set of rehabilitation exercise for the patients with interstitial lung diseases(ILD) and lung fibrosis staging system by artificial intelligence. Established an analysis system and clinical route for differential diagnosis of ILD. Created sets of new ways for differential diagnosis between sarcoidosis and sputum negative tuberculosis, elevated the correct diagnosis over 74%. Established a general therapeutic method majorly with Azithromycin for diffuse panbronchiolitis(DPB) and the patients’s 5 year survival reached 95%. Application for patent of invention over 10 (there are 4 international patents of them) and got 6 authorization，got two of copyright registration. Published over 160 pieces of scientific paper as corresponding & first author. Got 6 grants from Natural Science Foundation of China, in charge of the item “The Key Department of Chinese National Ministry of Health”, accumulated funding over 20 million. Publication of two books as chief editor.